| |
| |
|
| Insider
Information: |
Sarena Francis Willard |
| Relationship: |
President and COO |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
5,756 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,217 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
5,756 |
|
|
| Total
Value |
$14,217 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PDL Biopharma Inc |
PDLI |
VP/Gen Counsel/Secy |
2008-09-15 |
5,756 |
|
0 |
Premium* |
|
|
Five Prime Therapeutics Inc |
FPRX |
Chief Strategy Officer |
2021-04-16 |
0 |
2021-04-16 |
0 |
Premium* |
|
|
Apexigen Ord Shs |
APGN |
President and COO |
2023-08-23 |
0 |
2022-10-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PDLI |
PDL Biopharma Inc |
Exec Dir/Chief Legal Off/Secy |
• – – |
2008-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
6,292 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
SVP, Gen Counsel & Secretary |
• – – |
2015-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
6,110 |
8,570 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP, Gen Counsel & Secretary |
• – – |
2015-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
83,570 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP, Gen Counsel and Secretary |
• – – |
2016-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
93,834 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Strategy Officer |
• – – |
2016-09-08 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
81,266 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Strategy Officer |
• – – |
2017-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
16,078 |
94,902 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Strategy Officer |
• – – |
2018-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,923 |
78,099 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Strategy Officer |
• – – |
2019-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
84,149 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Strategy Officer |
• – – |
2020-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
108,178 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Strategy Officer |
• – – |
2021-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
66,000 |
169,468 |
0 |
- |
|
| APGN |
Apexigen Ord Shs |
Chief Operating Officer |
• – – |
2022-10-07 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
0 |
- |
|
| APGN |
Apexigen Ord Shs |
President and COO |
• – – |
2023-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
183,084 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP, Gen Counsel & Secretary |
• – – |
2016-01-27 |
4 |
AS |
$34.73 |
$1,056,609 |
D/D |
(30,000) |
83,570 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP, Gen Counsel and Secretary |
• – – |
2016-03-29 |
4 |
AS |
$40.00 |
$178,000 |
D/D |
(4,450) |
83,834 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP, Gen Counsel and Secretary |
• – – |
2016-03-30 |
4 |
AS |
$40.01 |
$222,056 |
D/D |
(5,550) |
83,834 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Strategy Officer |
• – – |
2016-11-23 |
4 |
AS |
$60.23 |
$810,997 |
D/D |
(13,465) |
81,266 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Strategy Officer |
• – – |
2016-11-25 |
4 |
AS |
$60.48 |
$1,281,511 |
D/D |
(21,189) |
81,266 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Strategy Officer |
• – – |
2016-11-28 |
4 |
AS |
$60.14 |
$102,839 |
D/D |
(1,710) |
81,266 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Strategy Officer |
• – – |
2017-01-18 |
4 |
AS |
$47.39 |
$172,310 |
D/D |
(3,636) |
78,824 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
VP/Gen Counsel/Secy |
• – – |
2008-09-15 |
4 |
D |
$10.84 |
$5,810 |
D/D |
(536) |
5,756 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP, Gen Counsel and Secretary |
• – – |
2016-09-01 |
4 |
D |
$44.74 |
$875,472 |
D/D |
(19,568) |
74,266 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Strategy Officer |
• – – |
2017-01-03 |
4 |
D |
$48.60 |
$118,681 |
D/D |
(2,442) |
78,824 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Strategy Officer |
• – – |
2017-03-01 |
4 |
D |
$44.77 |
$885,730 |
D/D |
(19,784) |
75,118 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Strategy Officer |
• – – |
2017-03-01 |
4 |
D |
$34.34 |
$107,519 |
D/D |
(3,131) |
71,987 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Strategy Officer |
• – – |
2018-09-01 |
4 |
D |
$14.00 |
$39,340 |
D/D |
(2,810) |
76,177 |
0 |
- |
|
58 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
